Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
- Status
- COMPLETED
- Phase
- N/A
Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
- Status
- COMPLETED
- Phase
- N/A
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?
- Status
- COMPLETED
- Phase
- N/A
Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)
- Status
- TERMINATED
- Phase
- PHASE3
EPO Deep Tank in Dialysis Subjects
- Status
- COMPLETED
- Phase
- PHASE3
A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE3
A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin
- Status
- COMPLETED
- Phase
- N/A
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2